Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
The past, present, and future of antibiotics
MA Cook, GD Wright - Science translational medicine, 2022 - science.org
Antibiotics have transformed modern medicine. They are essential for treating infectious
diseases and enable vital therapies and procedures. However, despite this success, their …
diseases and enable vital therapies and procedures. However, despite this success, their …
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
Photocatalytic antimicrobials: principles, design strategies, and applications
B Ran, L Ran, Z Wang, J Liao, D Li, K Chen… - Chemical …, 2023 - ACS Publications
Nowadays, the increasing emergence of antibiotic-resistant pathogenic microorganisms
requires the search for alternative methods that do not cause drug resistance. Phototherapy …
requires the search for alternative methods that do not cause drug resistance. Phototherapy …
Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives
The increasing incidence of drug-resistant pathogens raises an urgent need to identify and
isolate new bioactive compounds from medicinal plants using standardized modern …
isolate new bioactive compounds from medicinal plants using standardized modern …
[HTML][HTML] Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome
Antibiotic resistance is a major health concern globally and has been estimated to cause 10
million deaths worldwide by year 2050 if the current trend of inappropriate and excessive …
million deaths worldwide by year 2050 if the current trend of inappropriate and excessive …
A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex
Klebsiella pneumoniae is a leading cause of antimicrobial-resistant (AMR) healthcare-
associated infections, neonatal sepsis and community-acquired liver abscess, and is …
associated infections, neonatal sepsis and community-acquired liver abscess, and is …
[PDF][PDF] 多重耐药菌医院感染预防与控制中国专家共识
黄勋， 邓子德， 倪语星， 邓敏， 胡必杰， 李六亿… - 中国感染控制 …, 2015 - sph.54doctors.net
黄勋1, 邓子德2, 倪语星3, 邓敏4, 胡必杰5, 李六亿6, 李家斌7, 周伯平8, 王选锭9, 宗志勇10,
刘正印11, 任南1, 李卫光12, 邹明祥1, 徐修礼13, 周建英14, 侯铁英15, 鲜于舒铭16, 胡成平1 …
刘正印11, 任南1, 李卫光12, 邹明祥1, 徐修礼13, 周建英14, 侯铁英15, 鲜于舒铭16, 胡成平1 …
The multifaceted nature of antimicrobial peptides: Current synthetic chemistry approaches and future directions
BH Gan, J Gaynord, SM Rowe, T Deingruber… - Chemical Society …, 2021 - pubs.rsc.org
Bacterial infections caused by 'superbugs' are increasing globally, and conventional
antibiotics are becoming less effective against these bacteria, such that we risk entering a …
antibiotics are becoming less effective against these bacteria, such that we risk entering a …
Hospital-acquired infections in critically ill patients with COVID-19
Background Few small studies have described hospital-acquired infections (HAIs) occurring
in patients with COVID-19. Research Question What characteristics in critically ill patients …
in patients with COVID-19. Research Question What characteristics in critically ill patients …